Algenis - Empresa líder en la producción y el desarrollo clínico de moléculas bioactivas con uso médico

Production

The company has laboratories from where varied studies are conducted to provide production, chemical analysis and quality control alternatives. Additionally, these facilities have their own capacity for the production of specific compounds, process simulation, and efficacy and performance studies. It is here precisely, where Algenis put into practice a proprietary production method to purify PSTs molecules from natural marine resources.

The production of these molecules is initially carried out in our laboratories and depending on the target market, it is finished in accredited quality plants for each use (e.g: Injectable product is manufactured as a pharmaceutical drug in a GMP facility in the USA). Additionally, the company is investigating other raw materials to produce PSTs, with the financial support of “Corporación de Fomento de Chile”.